AdvanSix Announces Third Quarter 2025 Financial Results

Core Insights - AdvanSix reported a decline in sales and earnings for the third quarter of 2025, reflecting ongoing challenges in the industry, particularly in the Nylon Solutions and Chemical Intermediates segments [1][2][3] Financial Performance - Sales for Q3 2025 were $374 million, a decrease of approximately 6% compared to the prior year [3][4] - Net income for the quarter was a loss of $2.6 million, compared to a profit of $22.3 million in Q3 2024, representing a variance of $24.9 million [4][6] - Diluted earnings per share were ($0.10), down from $0.82 in the same quarter last year, while adjusted diluted earnings per share were $0.08, down from $0.88 [4][6] - Adjusted EBITDA was $24.7 million, a decrease of $28.4 million year-over-year, primarily due to lower pricing in Chemical Intermediates and reduced sales volume in Nylon [6][11] Operational Highlights - The company experienced a 3% decrease in sales volume, mainly due to weaker demand in chemical intermediates and nylon markets [3][4] - Raw material pass-through pricing decreased by approximately 5%, influenced by lower costs of benzene and propylene [3][4] - The company is moderating production rates to manage inventory levels and maintain free cash flow [2][9] Product Line Performance - Sales by product line for Q3 2025 included: - Nylon: $79 million (21% of total sales) - Caprolactam: $73 million (20%) - Plant Nutrients: $138 million (37%) - Chemical Intermediates: $83 million (22%) [5][4] Cash Flow and Capital Expenditures - Cash flow from operations was $26.6 million, down $30.7 million from the previous year [7][20] - Capital expenditures for the quarter were $26.5 million, a decrease of $4 million compared to Q3 2024 [7][20] - Free cash flow was reported at $66 thousand, significantly lower than $26.8 million in the prior year [21] Future Outlook - The company anticipates continued strength in Plant Nutrients and expects cash flow benefits from carbon capture tax credits in 2026 [9][11] - Capital expenditures for 2025 are projected to be between $120 million and $125 million, reflecting a focus on cash conservation [11][9] Dividend Declaration - The Board of Directors declared a quarterly cash dividend of $0.16 per share, payable on December 2, 2025 [10]